- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Podcast: This Week in Managed Care—Opioid Ruling and Settlement, and Other Health News
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care stories included a huge ruling against one opioid maker and a settlement offer from another; an expert panel calling for broader screening for hepatitis C; a review showing there are more fatal events linked to a multiple sclerosis drug than previously known.
Listen above or through one of these podcast services:
What We're Reading: Purdue Pharma Settlement; HCV Screening; Medicare for All Support
Fatal AEs Associated With Alemtuzumab for MS May Occur More Frequently Than Previously Thought
FDA Grants Fast Track Designation for Dapagliflozin to Prevent Kidney Failure
5 Things to Look for at the European Society of Cardiology 2019 Congress
Keeping Glucose in Range, With the Right Tools and Treatment for Management
IVBM: Advancing Oncology Quality Through Value-Based Care
Read more about the stories in this podcast:
Negotiations to extend US global HIV/AIDS relief work are deadlocked; the Biden administration delayed its rule on the proposed menthol cigarette ban until March 2024 after lobbying by civil rights groups; federal agencies have partnered with a digital health company to create an at-home test-to-treat program for flu and COVID-19.
Read More
Patient-Reported Outcomes Reinforce Efficacy of Natalizumab for MS
November 21st 2023Researchers gathered data on patient-reported outcomes to support evidence for the continuation of natalizumab, a disease-modifying treatment, in the management of multiple sclerosis (MS) progression.
Read More
Cognitive Benefits in Multiple Sclerosis Seen After Transcranial Current Stimulation
November 17th 2023Patients with multiple sclerosis (MS) showed cognitive improvements with frontal theta-transcranial alternating current stimulation (tACS), suggesting its potential as a tolerable and beneficial intervention.
Read More
